[Effects of intravitreal steroid injection on rabbit eye]. 1989

H Shimada, and M Matsui

In a previous study by the authors, it was determined that irrigation solutions containing an anti-prostaglandin agent had the capability of preventing the occurrence of blood-ocular barrier disruptions, retinal edema and post-operative inflammation following vitrectomy. However, not only prostaglandins but also leukotrienes, noted for their migratory effect on leukocytes, have cell migratory effect on the retinal pigment epithelial cells. Therefore, irrigation solutions containing an anti-prostaglandin agent and a steroid are expected to have the capability of preventing the occurrence of proliferative vitreoretinopathy and post-operative inflammation after vitrectomy. In this experiment, two kinds of steroids were injected into rabbit vitreous cavities in order to evaluate toxicity and to establish the toxic intravitreal dose of steroids on intraocular tissue. After paracentesis, 36 eyes of 18 rabbits were injected with dexamethasone sodium phosphate or betamethasone sodium phosphate, suspended in 0.3 ml of distilled water. Each steroid has the same molecular weight and almost the same clinical effects. The four eyes of two rabbits received 0.3 ml of physiologic saline as a control. All eyes were observed histologically seven days after the injection. It was proved that each steroid had almost the same toxicity for the same concentration and all steroids at dose less than five mg did not show toxicity on intraocular tissue. With all steroids, 10mg produced localized retinal degeneration at the inferior region of the posterior fundus. Twenty mg caused more extensive retinal degeneration. At a dose of 80 mg each steroid caused corneal edema, degeneration of ciliary bodies, fibrin formation in the vitreous body and degeneration of retinal cells throughout the retina. Considering the osmolarity and pH of each steroid solution, it was concluded that less than five mg of each of the steroids did not cause retinotoxicity, whereas more than 10 mg of any steroid did cause retinotoxicity.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm
D014822 Vitreous Body The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe. Vitreous Humor,Bodies, Vitreous,Body, Vitreous,Humor, Vitreous,Humors, Vitreous,Vitreous Bodies,Vitreous Humors

Related Publications

H Shimada, and M Matsui
August 1987, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
H Shimada, and M Matsui
January 1988, International ophthalmology,
H Shimada, and M Matsui
November 2005, Archives of ophthalmology (Chicago, Ill. : 1960),
H Shimada, and M Matsui
January 1992, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
H Shimada, and M Matsui
February 1992, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
Copied contents to your clipboard!